Anti-CD47 Antibody, CC-90002, in Combination with Rituximab in Subjects with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)

Por: Abrisqueta, P, Sancho, JM, Cordoba, R, Persky, DO, Andreadis, C, Huntington, SF, Carpio, C, Giles, DM, Wei, X, Li, YF, Zuraek, M, Burgess, MR, Hege, K and Martin, A

---

Publicada: 13 nov 2019

---

---

Filiaciones:
Abrisqueta, P:
 Hosp Univ Vall dHebron, Barcelona, Spain

:
 ICO IJC Hosp Germans Trias & Pujol, Barcelona, Spain

Cordoba, R:
 Hosp Univ Fdn Jimenez Diaz, START Madrid FJD, Madrid, Spain

Persky, DO:
 Univ Arizona, Canc Ctr, Tucson, AZ USA

Andreadis, C:
 Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

Huntington, SF:
 Yale Canc Ctr, New Haven, CT USA

Carpio, C:
 Hosp Univ Vall dHebron, Barcelona, Spain

Giles, DM:
 Hosp Univ Fdn Jimenez Diaz, START Madrid FJD, Madrid, Spain

Wei, X:
 Celgene Corp, Berkeley, NJ USA

Li, YF:
 Celgene Corp, Summit, NJ USA

Zuraek, M:
 Celgene Corp, San Francisco, CA USA

Burgess, MR:
 Celgene Corp, San Francisco, CA USA

Hege, K:
 Celgene Corp, San Francisco, CA USA

Martin, A:
 Hosp Univ Salamanca Clin, Salamanca, Spain